all three of the treatment regimens , methotrexate , adriamycin plus cyclophosphamide , cis-platinum plus 5-fluorouracil plus cyclophosphamide , showed similar survival and progression-free survival intervals .
C0010583
cyclophosphamide
C0055160
fluorouracil